New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA.

Published

Journal Article (Review)

Full Text

Duke Authors

Cited Authors

  • Pisetsky, DS; Rovin, BH; Lipsky, PE

Published Date

  • March 2017

Published In

Volume / Issue

  • 69 / 3

Start / End Page

  • 487 - 493

PubMed ID

  • 27899010

Pubmed Central ID

  • 27899010

Electronic International Standard Serial Number (EISSN)

  • 2326-5205

Digital Object Identifier (DOI)

  • 10.1002/art.40008

Language

  • eng

Conference Location

  • United States